Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Ltd. is set to hold an Extraordinary General Meeting on December 4, 2024, both in-person and online, offering shareholders the chance to engage actively in the company’s strategic discussions. This meeting presents an opportunity for investors to stay informed and potentially influence the company’s future directions. Shareholders can participate virtually via a webcast or submit their votes using a proxy form.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
